| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.033 | 0.6 |